Tagrisso 80mg Tablet

About Tagrisso 80mg Tablet

Tagrisso 80 mg Tablet is an anti-cancer medication used in the treatment of non-small cell lung cancer (NSCLC). It contains Osimertinib, a targeted therapy that works by blocking specific proteins (EGFR mutations) responsible for the growth and spread of cancer cells. It is commonly prescribed for patients whose cancer has specific EGFR mutations, including T790M mutation.

Tagrisso is known for its effectiveness and is generally better tolerated compared to conventional chemotherapy.

• Treatment of EGFR mutation-positive non-small cell lung cancer

• Used in advanced or metastatic lung cancer cases as prescribed by an oncologist

• Targeted therapy with high efficacy

• Helps slow down cancer progression

• Oral administration for patient convenience

• Suitable for long-term cancer management under medical supervision

Dosage should be taken as directed by the physician. Do not alter or discontinue the medication without medical advice.

• Store at room temperature

• Keep away from moisture and direct sunlight

• Keep out of reach of children

• For prescription use only

• Not recommended during pregnancy or breastfeeding unless advised by a doctor

• Regular medical monitoring is required during treatment